| 04/23/2026 3:30 PM | Structure Therapeutics (1888886) Filer | Form DEF 14A | |
| 04/23/2026 3:35 PM | Structure Therapeutics (1888886) Filer | Form ARS | |
| 04/23/2026 3:19 PM | Lang Matthew (1712069) Reporting Structure Therapeutics (1888886) Issuer | Form 3 Initial statement of beneficial ownership of securities | |
| 04/23/2026 3:21 PM | Lang Matthew (1712069) Reporting Structure Therapeutics (1888886) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 04/16/2026 1:17 PM | FMR LLC (315066) Reporting Structure Therapeutics (1888886) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 04/15/2026 5:05 AM | Structure Therapeutics (1888886) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 03/23/2026 3:30 PM | Stevens Raymond C (1698149) Reporting Structure Therapeutics (1888886) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/23/2026 3:30 PM | Structure Therapeutics (1888886) Issuer Yoon Jun (1962414) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/23/2026 3:30 PM | Lin Xichen (1962926) Reporting Structure Therapeutics (1888886) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/23/2026 3:30 PM | Ma Yingli (1963664) Reporting Structure Therapeutics (1888886) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/23/2026 3:30 PM | Coll Crespo Blas (2037144) Reporting Structure Therapeutics (1888886) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
Get the Latest News and Ratings for GPCR and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Structure Therapeutics and its competitors with MarketBeat's FREE daily newsletter.
|
| 03/23/2026 3:30 PM | Hall Ashley (1801842) Reporting Structure Therapeutics (1888886) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/16/2026 7:01 AM | Structure Therapeutics (1888886) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 03/05/2026 5:20 PM | Stevens Raymond C (1698149) Reporting Structure Therapeutics (1888886) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/05/2026 5:20 PM | Hall Ashley (1801842) Reporting Structure Therapeutics (1888886) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/05/2026 5:20 PM | Structure Therapeutics (1888886) Issuer Yoon Jun (1962414) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/05/2026 5:20 PM | Lin Xichen (1962926) Reporting Structure Therapeutics (1888886) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/05/2026 5:20 PM | Ma Yingli (1963664) Reporting Structure Therapeutics (1888886) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/05/2026 5:20 PM | Coll Crespo Blas (2037144) Reporting Structure Therapeutics (1888886) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/26/2026 4:22 PM | Structure Therapeutics (1888886) Filer | Form S-8 Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
| 02/26/2026 3:11 PM | Structure Therapeutics (1888886) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 02/13/2026 7:46 AM | Deep Track Capital, LP (1856083) Filed by Structure Therapeutics (1888886) Subject | Form SCHEDULE 13G/A | |
| 02/10/2026 10:23 AM | Structure Therapeutics (1888886) Subject WELLINGTON MANAGEMENT GROUP LLP (902219) Filed by | Form SCHEDULE 13G/A | |
| 02/05/2026 12:40 PM | FMR LLC (315066) Filed by Structure Therapeutics (1888886) Subject | Form SCHEDULE 13G/A | |
| 01/20/2026 8:22 AM | FMR LLC (315066) Reporting Structure Therapeutics (1888886) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 01/05/2026 3:07 PM | Structure Therapeutics (1888886) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 12/10/2025 4:04 PM | Structure Therapeutics (1888886) Filer | Form 424B5 | |
| 12/10/2025 4:06 PM | Structure Therapeutics (1888886) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 12/10/2025 1:07 PM | FMR LLC (315066) Reporting Structure Therapeutics (1888886) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 12/08/2025 4:28 PM | Structure Therapeutics (1888886) Filer | Form 424B5 | |
| 12/08/2025 7:47 AM | Structure Therapeutics (1888886) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 11/14/2025 8:01 AM | Avoro Capital Advisors LLC (1633313) Filed by Structure Therapeutics (1888886) Subject | Form SCHEDULE 13G | |
| 11/14/2025 7:15 AM | Deep Track Capital, LP (1856083) Filed by Structure Therapeutics (1888886) Subject | Form SCHEDULE 13G/A | |
| 11/07/2025 7:18 AM | Structure Therapeutics (1888886) Subject WELLINGTON MANAGEMENT GROUP LLP (902219) Filed by | Form SCHEDULE 13G/A | |
| 11/07/2025 7:16 AM | Structure Therapeutics (1888886) Subject WELLINGTON MANAGEMENT GROUP LLP (902219) Filed by | Form SCHEDULE 13G/A | |
| 11/06/2025 3:59 PM | Structure Therapeutics (1888886) Filer | Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
| 11/06/2025 3:15 PM | Structure Therapeutics (1888886) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 09/22/2025 8:25 PM | Coll Crespo Blas (2037144) Reporting Structure Therapeutics (1888886) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 09/22/2025 8:25 PM | Hall Ashley (1801842) Reporting Structure Therapeutics (1888886) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 08/20/2025 4:00 PM | Lin Xichen (1962926) Reporting Structure Therapeutics (1888886) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 08/20/2025 4:00 PM | Ma Yingli (1963664) Reporting Structure Therapeutics (1888886) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
|
| 08/18/2025 4:02 PM | BIOTECHNOLOGY VALUE FUND L P (918923) Filed by Structure Therapeutics (1888886) Subject | Form SCHEDULE 13G | |
| 08/14/2025 10:26 AM | JANUS HENDERSON GROUP PLC (1274173) Filed by Structure Therapeutics (1888886) Subject | Form SCHEDULE 13G/A | |
| 08/14/2025 7:46 AM | Deep Track Capital, LP (1856083) Filed by Structure Therapeutics (1888886) Subject | Form SCHEDULE 13G/A | |
| 08/12/2025 10:20 AM | Structure Therapeutics (1888886) Subject WELLINGTON MANAGEMENT GROUP LLP (902219) Filed by | Form SCHEDULE 13G/A | |
| 08/06/2025 4:16 PM | Structure Therapeutics (1888886) Filer | Form S-3ASR | |
| 08/06/2025 3:28 PM | Structure Therapeutics (1888886) Filer | Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
| 08/06/2025 11:14 AM | FMR LLC (315066) Filed by Structure Therapeutics (1888886) Subject | Form SCHEDULE 13G/A | |
| 08/01/2025 8:34 AM | FMR LLC (315066) Reporting Structure Therapeutics (1888886) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 07/03/2025 4:15 PM | Stevens Raymond C (1698149) Reporting Structure Therapeutics (1888886) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 07/03/2025 4:15 PM | Structure Therapeutics (1888886) Issuer Yoon Jun (1962414) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 07/03/2025 4:15 PM | Lin Xichen (1962926) Reporting Structure Therapeutics (1888886) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 07/03/2025 4:15 PM | Ma Yingli (1963664) Reporting Structure Therapeutics (1888886) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 07/03/2025 4:15 PM | Coll Crespo Blas (2037144) Reporting Structure Therapeutics (1888886) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/25/2025 4:45 PM | Structure Therapeutics (1888886) Issuer WELCH DANIEL G (1206199) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/25/2025 4:45 PM | Structure Therapeutics (1888886) Issuer TETLOW SHARON (1328565) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/25/2025 4:45 PM | DOBMEIER ERIC (1202785) Reporting Structure Therapeutics (1888886) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/25/2025 4:45 PM | Structure Therapeutics (1888886) Issuer Waldstreicher Joanne (1962413) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/25/2025 4:45 PM | LOVE TED W (1188919) Reporting Structure Therapeutics (1888886) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/25/2025 4:45 PM | Russell Angus C. (1534002) Reporting Structure Therapeutics (1888886) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/25/2025 3:15 PM | Structure Therapeutics (1888886) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 05/15/2025 7:42 AM | Deep Track Capital, LP (1856083) Filed by Structure Therapeutics (1888886) Subject | Form SCHEDULE 13G/A | |
| 05/14/2025 11:32 AM | JANUS HENDERSON GROUP PLC (1274173) Filed by Structure Therapeutics (1888886) Subject | Form SCHEDULE 13G/A | |
| 05/13/2025 10:32 AM | Capital Research Global Investors (1422848) Filed by Structure Therapeutics (1888886) Subject | Form SCHEDULE 13G/A | |
| 05/08/2025 3:30 PM | Structure Therapeutics (1888886) Filer | Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |